Device Breast and Skeletal Health

None

Payments companies reported to CMS as associated with None. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$345Kassociated payments (2023-2025)

193clinicians with associated payments

13companies reporting

By year

2023 $48.37

2024 $119K

2025 $226K

Payments reported as associated with None, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Diagnostic Radiology $72K

Gynecology $65K

Obstetrics & Gynecology $47K

Surgery $28K

Surgical Oncology $20K

Neurological Surgery $17K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with None

These are the largest totals companies reported as associated with None. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
David Toub	Wyncote, PA	Gynecology	$29,399.68
Jessica Shepherd	Dallas, TX	Gynecology	$26,300.00
Susan Boolbol	Poughkeepsie, NY	Surgery	$19,500.00
Sarah Friedewald	Boston, MA	Diagnostic Radiology	$15,933.98
Jason Katzen	Washington, DC	Diagnostic Radiology	$12,150.00
Shawna Willey	Fairfax, VA	Surgical Oncology	$11,690.06
Larry Khoo	Los Angeles, CA	Neurological Surgery	$10,362.90
Scott Blumenthal	Plano, TX	Orthopaedic Surgery of The Spine	$10,323.90
Lars Grimm	Durham, NC	Diagnostic Radiology	$8,576.95
Emily Fox Conant	Philadelphia, PA	Diagnostic Radiology	$8,000.00

Prescribed None?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.